Santa Cruz Biotechnology provides a broad selection of P2Y13 monoclonal antibodies for research focused on understanding P2Y13 receptor functions. P2Y13 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The P2Y13 receptor is a G protein-coupled receptor that plays a critical role in mediating cellular responses to extracellular nucleotides, particularly adenosine diphosphate (ADP). P2Y13 receptors are involved in various physiological processes, including platelet activation, immune response modulation, and regulation of vascular tone. Understanding P2Y13 receptor function is essential for elucidating its implications in cardiovascular diseases and other pathological conditions. Researchers can utilize P2Y13 monoclonal antibodies to explore receptor distribution patterns across different tissues and cell types. Advanced visualization techniques with P2Y13 monoclonal antibodies enable detailed examination of receptor localization and trafficking within cellular compartments. Secondary antibodies conjugated to horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) can be paired with P2Y13 monoclonal antibodies for enhanced detection sensitivity. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing understanding of P2Y13 receptor biology and its role in health and disease.